Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-25-019586

Options or other derivatives

  • Chief Executive Officer acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jahr Robert Charles Chief Executive Officer 2025-07-01 Grant or award · Stock Option (Right to Buy) +800,000 800,000 D
Loading xslF345X05/form4-07092025_090745.xml…